MAPT and Alzheimer disease: Based on the latest consensus, the definition of Alzheimer’s disease (AD) comprises clinical phenotypes and a biological construct composed of amyloid-β (Aβ) deposition, pathological tau, and neurodegeneration—the AT(N) research framework [1,2].